Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_assertion type Assertion NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_head.
- NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_assertion description "[FOXA1, estrogen receptor alpha (ERalpha) and GATA3 independently predict favorable outcome in breast cancer patients, and their expression correlates with a differentiated, luminal tumor subtype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_provenance.
- NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_assertion evidence source_evidence_literature NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_provenance.
- NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_assertion SIO_000772 20501593 NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_provenance.
- NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_assertion wasDerivedFrom befree-2016 NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_provenance.
- NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_assertion wasGeneratedBy ECO_0000203 NP814482.RAdEXbc8lHaS7LFIG8_5sMbbF44EXQG_LHQLt6JBoq5H0130_provenance.